Clinical

Dataset Information

0

Daily Online Adaptive Short-Course Radiation Therapy and Concurrent Chemotherapy for Muscle-Invasive Bladder Cancer


ABSTRACT: This trial is a single-arm, prospective, multi-center clinical trial designed to demonstrate that adaptive radiotherapy for muscle-invasive bladder cancer will translate into a decreased rate of acute (assessed weekly during chemo-radiotherapy) grade 3 or greater gastrointestinal/genitourinary toxicity compared with the historically reported rate for non-adaptive radiation therapy. The Common Terminology Criteria for Adverse Events (CTCAE) version 5 assessment tool will be utilized.

DISEASE(S): Carcinoma, Transitional Cell,Muscle Invasive Bladder Urothelial Carcinoma,Urinary Bladder Neoplasms

PROVIDER: 6198 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2710638 | ecrin-mdr-crc
2023-12-01 | GSE211148 | GEO
2023-12-01 | GSE211147 | GEO
2010-01-05 | GSE19716 | GEO
| 2143535 | ecrin-mdr-crc
| S-EPMC8609047 | biostudies-literature
| PRJNA869094 | ENA
| PRJNA913157 | ENA
| PRJNA947077 | ENA
2014-11-03 | GSE51603 | GEO